FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

387517004: Paracetamol (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1481607015 Acetaminophen en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
1492140010 Paracetamol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3482728017 Paracetamol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
51591000195119 paracetamolo it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
831131000172117 paracétamol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
65861000195116 Paracetamol de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
235861000195117 Acetaminophen de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Paracetamol Is a analgésique et antipyrétique false Inferred relationship Some
Paracetamol Is a classe d'allergènes false Inferred relationship Some
Paracetamol Is a Paracetamol or paracetamol derivative false Inferred relationship Some
Paracetamol Is a Para-aminophenol derivative anti-inflammatory agent false Inferred relationship Some
Paracetamol Is a Phenol and derivatives false Inferred relationship Some
Paracetamol Is a Amide false Inferred relationship Some
Paracetamol Is a Drug allergen by structure false Inferred relationship Some
Paracetamol Is a Para-aminophenol derivative true Inferred relationship Some
Paracetamol Is a Non-opioid analgesic (substance) true Inferred relationship Some
Paracetamol Is a Acetamide (substance) true Inferred relationship Some
Paracetamol Is a Phenol false Inferred relationship Some
Paracetamol Is a Substance with phenol structure true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing mefenamic acid and paracetamol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 2
Mefenamic acid and paracetamol only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 2
Product containing mefenamic acid and paracetamol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 2
Product containing only mefenamic acid and paracetamol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 2
Product containing precisely mefenamic acid 10 milligram/1 milliliter and paracetamol 25 milligram/1 milliliter conventional release oral suspension (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 1
Product containing precisely mefenamic acid 10 milligram/1 milliliter and paracetamol 25 milligram/1 milliliter conventional release oral suspension (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 1
Product containing precisely mefenamic acid 500 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 2
Product containing precisely mefenamic acid 500 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 2
Cetirizine hydrochloride 400 microgram/mL and paracetamol 25 mg/mL and phenylephrine hydrochloride 1 mg/mL oral suspension The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 2
Cetirizine hydrochloride 400 microgram/mL and paracetamol 25 mg/mL and phenylephrine hydrochloride 1 mg/mL oral suspension This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 2
Cetirizine- and paracetamol- and phenylephrine-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 3
Product containing only cetirizine and paracetamol and phenylephrine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 3
Product containing cetirizine and paracetamol and phenylephrine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 3
Product containing only cetirizine and paracetamol and phenylephrine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 3
Paracetamol 600 mg powder for oral solution sachet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 1
Paracetamol 600 mg powder for oral solution sachet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 1
Product containing precisely paracetamol 500 milligram/1 sachet powder for conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 1
Product containing precisely paracetamol 500 milligram/1 sachet powder for conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 1
Product containing precisely paracetamol 1 gram/1 sachet powder for conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 1
Product containing precisely paracetamol 1 gram/1 sachet powder for conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 1
Chlorzoxazone and diclofenac and paracetamol only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 1
Product containing chlorzoxazone and diclofenac and paracetamol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 1
Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 1
Chlorzoxazone 500 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 1
Chlorzoxazone- and diclofenac- and paracetamol-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 1
Chlorzoxazone and diclofenac and paracetamol only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 1
Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 1
Chlorzoxazone 250 mg and diclofenac sodium 50 mg and paracetamol 325 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 1
Product containing precisely chlorzoxazone 500 milligram and diclofenac potassium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 2
Product containing precisely chlorzoxazone 500 milligram and diclofenac potassium 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 2
Diclofenac and paracetamol and serrapeptase only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 1
Product containing diclofenac and paracetamol and serrapeptase in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 1
Product containing diclofenac and paracetamol and serrapeptase (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 1
Diclofenac and paracetamol and serrapeptase only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 1
Diclofenac potassium 50 mg and paracetamol 325 mg and serrapeptase 10 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 1
Diclofenac potassium 50 mg and paracetamol 325 mg and serrapeptase 10 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 1
Product containing precisely diclofenac potassium 50 milligram and paracetamol 325 milligram and serrapeptase 15 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 1
Product containing precisely diclofenac potassium 50 milligram and paracetamol 325 milligram and serrapeptase 15 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 1
Paracetamol 10 mg/mL solution for infusion The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 1
Paracetamol 10 mg/mL solution for infusion This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 1
Product containing precisely paracetamol 10 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 1
Product containing precisely paracetamol 10 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 1
Product containing precisely mefenamic acid 500 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 2
Product containing precisely mefenamic acid 500 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 2
Caffeine 32 mg and paracetamol 500 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 2
Caffeine 32 mg and paracetamol 500 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 2
Caffeine 25 mg and guaifenesin 100 mg and paracetamol 500 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 2
Caffeine 25 mg and guaifenesin 100 mg and paracetamol 500 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 2
Caffeine- and guaifenesin- and paracetamol-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 2
Caffeine and guaifenesin and paracetamol only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 2
Acetaminophen 500 mg and caffeine 30 mg and codeine phosphate 8 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 3
Acetaminophen 500 mg and caffeine 30 mg and codeine phosphate 8 mg oral capsule This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 3
Product containing precisely codeine phosphate 15 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 2
Product containing precisely codeine phosphate 15 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 2
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 2
Product containing precisely guaifenesin 100 milligram and paracetamol 500 milligram and phenylephrine (as phenylephrine hydrochloride) 5 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 2
Product containing guaifenesin and paracetamol and phenylephrine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 2
Guaifenesin and paracetamol and phenylephrine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 2
Guaifenesin and paracetamol and phenylephrine only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 2
Guaifenesin- and paracetamol- and phenylephrine-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 2
Product containing only dextromethorphan and paracetamol and promethazine in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 3
Product containing only dextromethorphan and paracetamol and promethazine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 3
Dextromethorphan- and paracetamol- and promethazine-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 3
Dextromethorphan- and paracetamol- and promethazine-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 3
Product containing precisely dextromethorphan hydrobromide 7.5 milligram and paracetamol 500 milligram and promethazine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 3
Product containing precisely dextromethorphan hydrobromide 7.5 milligram and paracetamol 500 milligram and promethazine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 3
Product containing precisely dextromethorphan hydrobromide 750 microgram/1 milliliter and paracetamol 50 milligram/1 milliliter and promethazine hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 3
Product containing precisely dextromethorphan hydrobromide 750 microgram/1 milliliter and paracetamol 50 milligram/1 milliliter and promethazine hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 3
Diphenhydramine hydrochloride 2.5 mg/mL and paracetamol 24 mg/mL oral solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 2
Diphenhydramine hydrochloride 2.5 mg/mL and paracetamol 24 mg/mL oral solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 2
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 3
Buclizine hydrochloride 6.25 mg and codeine phosphate 8 mg and paracetamol 500 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 3
Buclizine- and codeine- and paracetamol-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 3
Product containing only buclizine and codeine and paracetamol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 3
Product containing only buclizine and codeine and paracetamol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 3
Buclizine- and codeine- and paracetamol-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 3
Ibuprofen 150 mg and paracetamol 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 2
Ibuprofen 150 mg and paracetamol 500 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 2
Product containing precisely brompheniramine maleate 3 milligram and caffeine 30 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 3
Product containing precisely brompheniramine maleate 3 milligram and caffeine 30 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 3
Brompheniramine- and caffeine- and paracetamol-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 3
Brompheniramine and caffeine and paracetamol only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 3
Product containing only brompheniramine and caffeine and paracetamol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 3
Product containing brompheniramine and caffeine and paracetamol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 3
Product containing precisely caffeine 30 milligram and codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 3
Product containing precisely caffeine 30 milligram and codeine phosphate 8 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 3
Diphenhydramine hydrochloride 12.5 mg and paracetamol 500 mg and pseudoephedrine hydrochloride 22.5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 3
Diphenhydramine hydrochloride 12.5 mg and paracetamol 500 mg and pseudoephedrine hydrochloride 22.5 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 3
Diphenhydramine- and paracetamol- and pseudoephedrine-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 3
Diphenhydramine and paracetamol and pseudoephedrine only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 3
Product containing only diphenhydramine and paracetamol and pseudoephedrine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 3
Diphenhydramine- and paracetamol- and pseudoephedrine-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 3
Ibuprofen (as ibuprofen sodium) 3 mg/mL and paracetamol 10 mg/mL solution for infusion The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Paracetamol Inferred relationship Some 2
Ibuprofen (as ibuprofen sodium) 3 mg/mL and paracetamol 10 mg/mL solution for infusion This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Paracetamol Inferred relationship Some 2
Ibuprofen and paracetamol only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 2
Ibuprofen- and paracetamol-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Paracetamol Inferred relationship Some 2
Acetaminophen measurement, urine Component True Paracetamol Inferred relationship Some 1
Paracetamol blood measurement Component True Paracetamol Inferred relationship Some 1
Serum paracetamol measurement Component True Paracetamol Inferred relationship Some 1
Salicylate/paracetamol screening Component True Paracetamol Inferred relationship Some 1
Measurement of acetaminophen in gastric fluid (procedure) Component True Paracetamol Inferred relationship Some 1

Start Previous Page 10 of 11 End


This concept is not in any reference sets

Back to Start